期刊文献+

蛋白质组学在肝癌研究中的应用 被引量:5

Application of proteomics in hepatocellular carcinoma researches
在线阅读 下载PDF
导出
摘要 蛋白质组学以细胞组织或器官表达的所有蛋白质为研究对象,通过双向凝胶电泳生物质谱技术及生物信息学等方法,达到分离、鉴定、分析蛋白质的目的。在我国肝癌死亡率高,位居第二,预后差。以蛋白质组学的方法,通过比较肿瘤与正常肝组织之间蛋白质组的表达差异,发现新的肝癌肿瘤标志物,寻找与肝癌发生、发展、转移的相关蛋白,为肝癌治疗提供新的靶点。 Proteomics deals with all the proteins that expressed in cells, tissues or organs. By means of 2D- PAGE, MS and bioinfonnatics, we could separate, identify and analyze proteins, particularly their structures and functions. Hepatocellular carcinoma (HCC), with high mortality and poor prognosis, is the second most malignant tumors in our country. Proteomics has played an important role in diagnosis and treatment of HCC. We can detect the proteins differently expressed in tissues of liver cancer and normal liver by proteomies, discover new tumor markers, analyze whether it relates to the genesis, progression or metastasis of liver cancer, and find a new target for HCC treatment.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2012年第1期57-60,64,共5页 China Journal of Modern Medicine
基金 江西省卫生厅资助项目(No:20070454)
关键词 蛋白质组学 肝癌 双向凝胶电泳 proteomics hepatocellular carcinoma two-dimensional gel electrophoresis
  • 相关文献

参考文献3

二级参考文献11

  • 1Yan Li Zhao-You Tang Sheng-Long Ye Yin-Kun Liu Jie Chen Qiong Xue Jun Chen Dong-Mei Gao Wei-Hua Bao Liver Cancer Institute and Zhongshan Hospital of Hehai University (Former Liver Cancer Institute of Shanghai Medical University),Shanghai 200032,China.Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97[J].World Journal of Gastroenterology,2001,7(5):630-636. 被引量:113
  • 2李雁,汤钊猷,田波,钦伦秀,叶胜龙,孙瑞霞.细胞角质蛋白19与肝癌临床病理关系的探讨[J].中华肝脏病杂志,2004,12(6):341-343. 被引量:5
  • 3Nagasue N, Uchida M, Makino Y, et al. Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma. Gastroenterology, 1993, 105 : 488-494.
  • 4Taniguchi T, Makino M, Suzuki K, et al. Prognostic significance of reverse transcriptase-polymerase chain reaction measurement of careinoembryonic antigen mRNA levels in tumor drainage blood and peripheral blood of patients with colorectal carcinoma. Cancer,2000, 89:970-976.
  • 5Witzigznann H, Geissler F, Benedix F, et al. Prospective evaluation of circulating hepatocytes by alpha-fetoprotein messenger RNA in patients with hepatocellular carcinoma. Surgery, 2002, 131:34-43.
  • 6Tamaoki T, Fausto N. Expression of the α-fetoprotein gone during development, regeneration and carcinogenesis. In: Stein G, Stein J,eds. Recombinant DNA and Cell Proliferation. San Diego: Academic Press, 1984. 145-168.
  • 7Wong IH, Lau WY, Leung T, et al. Quantitative comparison of alpha-fetoprotein and albumin mRNA levels in hepatocellular carcinoma/adenoma, non-tumor liver and blood: implications in cancer detection and monitoring. Cancer Lett, 2000, 156:141-149.
  • 8Thomas Koperna,Michael Kisser,Franz Schulz.Hepatic Resection in the Elderly[J].World Journal of Surgery.1998(4)
  • 9伍龙,汤钊猷,李雁.肝癌模型的研究进展[J].中华实验外科杂志,2009,26(6):815-816. 被引量:12
  • 10蒋扬富,杨治华,胡敬群,杨晓洁,李申德.外周血AFP mRNA表达与原发性肝癌转移的关系[J].中华肿瘤杂志,1999,21(1):38-41. 被引量:17

共引文献14

同被引文献75

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部